Safety of Anti-Depressant for Chronic Obstructive Pulmonary Disease (SAD-COPD)

NCT02813447 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped COVID-19 hold

Conditions

COPD
Anxiety
Depression
Stress
Interstitial Lung Disease

Interventions

DRUG: Sertraline
DRUG: Placebo

Sponsor

Duke University